Published in J Virol on November 01, 1988
The dengue viruses. Clin Microbiol Rev (1990) 4.72
Modulation of Dengue virus infection in human cells by alpha, beta, and gamma interferons. J Virol (2000) 3.61
Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, whereas T- and B-cell-dependent immunity are less critical. J Virol (2004) 2.83
Infection of human cells by dengue virus is modulated by different cell types and viral strains. J Virol (2000) 2.49
Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue. J Clin Invest (1991) 2.37
American genotype structures decrease dengue virus output from human monocytes and dendritic cells. J Virol (2003) 2.03
Dengue viral infections. Postgrad Med J (2004) 2.03
Human T cell responses to dengue virus antigens. Proliferative responses and interferon gamma production. J Clin Invest (1989) 2.01
Dengue virus-specific human T cell clones. Serotype crossreactive proliferation, interferon gamma production, and cytotoxic activity. J Exp Med (1989) 1.68
Dengue virus-specific cross-reactive CD8+ human cytotoxic T lymphocytes. J Virol (1989) 1.55
Phenotyping of peripheral blood mononuclear cells during acute dengue illness demonstrates infection and increased activation of monocytes in severe cases compared to classic dengue fever. Virology (2008) 1.54
Differential enhancement of dengue virus immune complex infectivity mediated by signaling-competent and signaling-incompetent human Fcgamma RIA (CD64) or FcgammaRIIA (CD32). J Virol (2006) 1.34
Virus replication and cytokine production in dengue virus-infected human B lymphocytes. J Virol (2002) 1.25
Monoclonal antibody analysis of neutralization and antibody-dependent enhancement of feline infectious peritonitis virus. J Virol (1992) 1.24
Dengue virus-specific murine T-lymphocyte proliferation: serotype specificity and response to recombinant viral proteins. J Virol (1989) 1.20
Primary human splenic macrophages, but not T or B cells, are the principal target cells for dengue virus infection in vitro. J Virol (2007) 1.20
Aleutian mink disease parvovirus infection of mink macrophages and human macrophage cell line U937: demonstration of antibody-dependent enhancement of infection. J Virol (1993) 1.09
Two receptors are required for antibody-dependent enhancement of human immunodeficiency virus type 1 infection: CD4 and Fc gamma R. J Virol (1990) 1.08
Specific ablation of antiviral gene expression in macrophages by antibody-dependent enhancement of Ross River virus infection. J Virol (2000) 1.02
Detection of higher levels of dengue viremia using FcγR-expressing BHK-21 cells than FcγR-negative cells in secondary infection but not in primary infection. J Infect Dis (2011) 1.00
Antibody-dependent enhancement of hepatitis C virus infection. J Virol (2007) 0.96
Human FcγRII cytoplasmic domains differentially influence antibody-mediated dengue virus infection. J Immunol (2013) 0.96
The relationship of interacting immunological components in dengue pathogenesis. Virol J (2009) 0.93
Dengue and soluble mediators of the innate immune system. Trop Med Health (2011) 0.87
The NS1 glycoprotein can generate dramatic antibody-enhanced dengue viral replication in normal out-bred mice resulting in lethal multi-organ disease. PLoS One (2011) 0.86
Discrepancy in dengue virus neutralizing antibody titers between plaque reduction neutralizing tests with Fcgamma receptor (FcgammaR)-negative and FcgammaR-expressing BHK-21 cells. Clin Vaccine Immunol (2009) 0.86
Antibody-dependent enhancement of respiratory syncytial virus infection by sera from young infants. Clin Diagn Lab Immunol (1994) 0.84
Porcine FcγRIIb mediates enhancement of porcine reproductive and respiratory syndrome virus (PRRSV) infection. PLoS One (2011) 0.79
Association of Intracellular T(H)1-T(H)2 Balance in CD4+ T-cells and MIP-1α in CD8+ T-cells with Disease Severity in Adults with Dengue. Immune Netw (2010) 0.78
Molecular determinants of dengue virus 2 envelope protein important for virus entry in FcγRIIA-mediated antibody-dependent enhancement of infection. Virology (2014) 0.77
Sequential immunization with heterologous chimeric flaviviruses induces broad-spectrum cross-reactive CD8+ T cell responses. J Infect Dis (2010) 0.77
IgG Fc variant cross-reactivity between human and rhesus macaque FcγRs. MAbs (2017) 0.76
Dengue: A Clinicohaematological Profile. Med J Armed Forces India (2011) 0.75
Formation of infectious dengue virus-antibody immune complex in vivo in marmosets (Callithrix jacchus) after passive transfer of anti-dengue virus monoclonal antibodies and infection with dengue virus. Am J Trop Med Hyg (2014) 0.75
The high-affinity human IgG receptor Fc gamma receptor I (FcγRI) is not associated with vascular leakage of dengue. J Negat Results Biomed (2015) 0.75
Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int J Cancer (1976) 14.08
A prospective study of dengue infections in Bangkok. Am J Trop Med Hyg (1988) 8.54
Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody. J Exp Med (1977) 7.01
Expression of human immune interferon cDNA in E. coli and monkey cells. Nature (1982) 6.55
Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. Am J Epidemiol (1984) 5.62
Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered. Yale J Biol Med (1970) 4.30
In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody. J Infect Dis (1979) 3.90
Recombinant immune interferon increases immunoglobulin G Fc receptors on cultured human mononuclear phagocytes. J Clin Invest (1983) 3.32
Immune interferon induces the receptor for monomeric IgG1 on human monocytic and myeloid cells. J Exp Med (1983) 2.93
Dengue viruses and mononuclear phagocytes. II. Identity of blood and tissue leukocytes supporting in vitro infection. J Exp Med (1977) 2.84
Monoclonal antibodies to Fc receptors for IgG on human mononuclear phagocytes. Antibody characterization and induction of superoxide production in a monocyte cell line. J Biol Chem (1986) 2.01
The Alexander D. Langmuir Lecture. The pathogenesis of dengue. Molecular epidemiology in infectious disease. Am J Epidemiol (1981) 1.85
Lysis of dengue virus-infected cells by natural cell-mediated cytotoxicity and antibody-dependent cell-mediated cytotoxicity. J Virol (1984) 1.66
Immune interferon produced to high levels by antigenic stimulation of human lymphocytes with influenza virus. J Exp Med (1981) 1.64
Evidence for two mechanisms of dengue virus infection of adherent human monocytes: trypsin-sensitive virus receptors and trypsin-resistant immune complex receptors. Infect Immun (1981) 1.58
Induction of interferon alpha and gamma from human lymphocytes by dengue virus-infected cells. J Gen Virol (1986) 1.24
Human interferon alpha and gamma production by lymphocytes during the generation of influenza virus-specific cytotoxic T lymphocytes. J Gen Virol (1986) 1.14
Production of interferon alpha by dengue virus-infected human monocytes. J Gen Virol (1988) 1.08
Induction of interferon alpha from human lymphocytes by autologous, dengue virus-infected monocytes. J Exp Med (1987) 1.03
Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis (2000) 11.44
Dengue in the early febrile phase: viremia and antibody responses. J Infect Dis (1997) 5.13
Early clinical and laboratory indicators of acute dengue illness. J Infect Dis (1997) 5.00
Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry. Science (1988) 3.44
Immunopathogenesis of Dengue hemorrhagic fever. Virology (1999) 3.16
Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. J Infect Dis (1999) 2.96
Persistence of maternal antibody in infants beyond 12 months: mechanism of measles vaccine failure. J Pediatr (1977) 2.66
A controlled double-blind comparison of reactogenicity, immunogenicity, and protective efficacy of whole-virus and split-product influenza vaccines in children. J Infect Dis (1977) 2.55
Human CD8+ and CD4+ T lymphocyte memory to influenza A viruses of swine and avian species. J Immunol (1999) 2.54
Human IgG Fc receptor II mediates antibody-dependent enhancement of dengue virus infection. J Immunol (1990) 2.47
Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue. J Clin Invest (1991) 2.37
Human cytotoxic T-cell memory: long-lived responses to vaccinia virus. J Virol (1996) 2.35
Recovery from a viral respiratory infection. II. Passive transfer of immune spleen cells to mice with influenza pneumonia. J Immunol (1981) 2.19
HLA-A and -B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais. Tissue Antigens (2002) 2.18
Human cytotoxic T-lymphocyte repertoire to influenza A viruses. J Virol (1998) 2.10
Recovery from a viral respiratory infection. I. Influenza pneumonia in normal and T-deficient mice. J Immunol (1981) 2.04
High levels of cytokine-producing cells in the lung tissues of patients with fatal hantavirus pulmonary syndrome. J Infect Dis (1999) 2.02
Human T cell responses to dengue virus antigens. Proliferative responses and interferon gamma production. J Clin Invest (1989) 2.01
Hemagglutinin-specific cytotoxic T-cell response during influenza infection. J Exp Med (1977) 1.97
Human dendritic cells are activated by dengue virus infection: enhancement by gamma interferon and implications for disease pathogenesis. J Virol (2001) 1.92
Cytotoxic T lymphocyte response to murine cytomegalovirus infection. Nature (1978) 1.89
Influenza virus infection in nude mice. J Infect Dis (1976) 1.85
Early CD69 expression on peripheral blood lymphocytes from children with dengue hemorrhagic fever. J Infect Dis (1999) 1.82
An HLA-C-restricted CD8+ cytotoxic T-lymphocyte clone recognizes a highly conserved epitope on human immunodeficiency virus type 1 gag. J Virol (1991) 1.80
Elevated plasma interleukin-10 levels in acute dengue correlate with disease severity. J Med Virol (1999) 1.79
Summary of clinical trials of inactivated influenza vaccine - 1978. Rev Infect Dis (1983) 1.79
Rapid diagnosis of dengue viremia by reverse transcriptase-polymerase chain reaction using 3'-noncoding region universal primers. Am J Trop Med Hyg (1997) 1.75
Dengue virus-specific human T cell clones. Serotype crossreactive proliferation, interferon gamma production, and cytotoxic activity. J Exp Med (1989) 1.68
Serotype-cross-reactive immunoglobulin M responses in dengue virus infections determined by enzyme-linked immunosorbent assay. Clin Diagn Lab Immunol (2000) 1.67
Host defense mechanisms against Herpes simplex virus. I. Control of infection in vitro by senstized spleen cells and antibody. Infect Immun (1973) 1.67
Lysis of dengue virus-infected cells by natural cell-mediated cytotoxicity and antibody-dependent cell-mediated cytotoxicity. J Virol (1984) 1.66
Immune interferon produced to high levels by antigenic stimulation of human lymphocytes with influenza virus. J Exp Med (1981) 1.64
Serologic responses and systemic reactions in adults after vaccination with monovalent A/USSR/77 and trivalent A/USSR/77, A/Texas/77, B/Hong Kong/72 influenza vaccines. Rev Infect Dis (1983) 1.64
A CD4+ cytotoxic T-lymphocyte clone to a conserved epitope on human immunodeficiency virus type 1 p24: cytotoxic activity and secretion of interleukin-2 and interleukin-6. J Virol (1992) 1.63
Molecular evolution of dengue type 2 virus in Thailand. Am J Trop Med Hyg (1998) 1.63
Immunopathologic mechanisms of dengue hemorrhagic fever and dengue shock syndrome. Arch Virol Suppl (1994) 1.61
The importance of an intact complement pathway in recovery from a primary viral infection: influenza in decomplemented and in C5-deficient mice. J Immunol (1978) 1.60
Purification of influenza virus glycoproteins for the preparation and standardization of immunological potency testing reagents. J Biol Stand (1980) 1.59
High levels of interferon alpha in the sera of children with dengue virus infection. Am J Trop Med Hyg (1993) 1.56
Dengue virus-specific cross-reactive CD8+ human cytotoxic T lymphocytes. J Virol (1989) 1.55
Specificity studies on cytotoxic thymus-derived lymphocytes reactive with influenza virus-infected cells: evidence for dual recognition of H-2 and viral hemagglutinin antigens. Proc Natl Acad Sci U S A (1977) 1.53
Dengue virus-specific, human CD4+ CD8- cytotoxic T-cell clones: multiple patterns of virus cross-reactivity recognized by NS3-specific T-cell clones. J Virol (1991) 1.52
Transfer of measles, mumps, and rubella antibodies from mother to infant. Its effect on measles, mumps, and rubella immunization. Am J Dis Child (1979) 1.51
Antibody-dependent enhancement of dengue virus infection mediated by bispecific antibodies against cell surface molecules other than Fc gamma receptors. J Immunol (1991) 1.50
Impaired T cell proliferation in acute dengue infection. J Immunol (1999) 1.46
Mutation of human immunodeficiency virus type 1 at amino acid 585 on gp41 results in loss of killing by CD8+ A24-restricted cytotoxic T lymphocytes. J Virol (1992) 1.46
Laboratory diagnosis of dengue virus infection by reverse transcriptase polymerase chain reaction (RT-PCR) and IgM-capture enzyme-linked immunosorbent assay (ELISA). Jpn J Infect Dis (1999) 1.44
Fatal measles infection in marmosets pathogenesis and prophylaxis. Infect Immun (1980) 1.43
Host defense mechanisms against herpes simplex virus. II. Protection conferred by sensitized spleen cells. J Infect Dis (1973) 1.39
Enzyme-linked immunosorbent assays for detection of antibodies to Ebola and Marburg viruses using recombinant nucleoproteins. J Clin Microbiol (2001) 1.39
Influenza virus hemagglutinin-specific cytotoxic T cell response induced by polypeptide produced in Escherichia coli. J Exp Med (1985) 1.37
Dominant recognition by human CD8+ cytotoxic T lymphocytes of dengue virus nonstructural proteins NS3 and NS1.2a. J Clin Invest (1996) 1.35
Clinical studies with experimental live rubella virus vaccine (strain HPV-77). Evaluation of vaccine-induced immunity. Am J Dis Child (1968) 1.34
Dengue virus-specific, HLA-B35-restricted, human CD8+ cytotoxic T lymphocyte (CTL) clones. Recognition of NS3 amino acids 500 to 508 by CTL clones of two different serotype specificities. J Immunol (1995) 1.32
Predominance of HLA-restricted cytotoxic T-lymphocyte responses to serotype-cross-reactive epitopes on nonstructural proteins following natural secondary dengue virus infection. J Virol (1998) 1.31
Bystander target cell lysis and cytokine production by dengue virus-specific human CD4(+) cytotoxic T-lymphocyte clones. J Virol (1999) 1.29
HLA restricted virus-specific cytotoxic T-lymphocyte responses to live and inactivated influenza vaccines. Lancet (1981) 1.28
Identification of amino acids involved in recognition by dengue virus NS3-specific, HLA-DR15-restricted cytotoxic CD4+ T-cell clones. J Virol (1996) 1.28
Dengue-2 virus infection of human mononuclear cell lines and establishment of persistent infections. Arch Virol (1990) 1.27
Specific lysis of human immunodeficiency virus type 1-infected cells by a HLA-A3.1-restricted CD8+ cytotoxic T-lymphocyte clone that recognizes a conserved peptide sequence within the gp41 subunit of the envelope protein. Proc Natl Acad Sci U S A (1991) 1.26
Sensitive neutralization test for virus antibody. 1. Mumps antibody. Arch Virol (1978) 1.25
Molecular characterization of the E gene of dengue virus type 1 isolated in Guangdong province, China, in 2006. Epidemiol Infect (2008) 1.25
Evidence that cytotoxic T cells are part of the host's response to influenza pneumonia. J Exp Med (1978) 1.25
Latent cytomegalovirus infection of BALB/c mouse spleens detected by an explant culture technique. J Gen Virol (1979) 1.24
High levels of viremia in patients with the Hantavirus pulmonary syndrome. J Infect Dis (1999) 1.24
Induction of interferon alpha and gamma from human lymphocytes by dengue virus-infected cells. J Gen Virol (1986) 1.24
Analysis of plasma viral RNA levels during acute dengue virus infection using quantitative competitor reverse transcription-polymerase chain reaction. J Med Virol (2001) 1.24
Confirmation of dengue virus infection by detection of dengue virus type 1 genome in urine and saliva but not in plasma. Trans R Soc Trop Med Hyg (2007) 1.24
Vaccinia virus-specific CD8+ cytotoxic T lymphocytes in humans. J Virol (1993) 1.23
Induction of protective immunity against Japanese encephalitis in mice by immunization with a plasmid encoding Japanese encephalitis virus premembrane and envelope genes. J Virol (1998) 1.23
Multiple specificities in the murine CD4+ and CD8+ T-cell response to dengue virus. J Virol (1996) 1.22
Interferon induction and increased natural killer-cell activity in influenza infections in man. Lancet (1981) 1.21
Specific IgM and IgG responses in primary and secondary dengue virus infections determined by enzyme-linked immunosorbent assay. Epidemiol Infect (2005) 1.21
Influenza A viruses of the H2N2 subtype are lymphocyte mitogens. Nature (1978) 1.20
Dengue virus-specific murine T-lymphocyte proliferation: serotype specificity and response to recombinant viral proteins. J Virol (1989) 1.20
Host defense mechanisms against influenza virus: interaction of influenza virus with murine macrophages in vitro. Infect Immun (1978) 1.19
Immunogenicity and reactogenicity of influenza A/New Jersey/76 virus vaccines in normal adults. J Infect Dis (1977) 1.16
Dengue virus infection of human skin fibroblasts in vitro production of IFN-beta, IL-6 and GM-CSF. Arch Virol (1992) 1.16
Safety and immunogenicity of NYVAC-JEV and ALVAC-JEV attenuated recombinant Japanese encephalitis virus--poxvirus vaccines in vaccinia-nonimmune and vaccinia-immune humans. Vaccine (2000) 1.15